Arrowhead Pharmaceuticals Inc (ARWR) with a beta value of 0.87 appears to be a promising investment opportunity.
On Friday, Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) was -3.96% drop from the session before settling in for the closing price of $17.67. A 52-week range